Latest Clinical trial Stories

goBalto Adds Site Collaboration and File Upload to Tracker 2.0, the Web-Based Platform for Study Startup

2013-05-01 12:31:15

Enhanced Functionality Adds Even Greater Efficiency SAN FRANCISCO, May 1, 2013 /PRNewswire/ -- goBalto, Inc. released new file management and site collaboration capabilities in the latest version of Tracker 2.0, the company's cloud-based solution that helps accelerate clinical trial startup. Tracker 2.0, goBalto's flagship product, is a software-as-a-service (SaaS) application that helps pharmaceutical, biotech, medical device companies, and small or large clinical research...

Celsion Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013

2013-05-01 08:31:29

LAWRENCEVILLE, N.J., May 1, 2013 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN) announced today that Professor Riccardo Lencioni, MD, FSIR, EBIR, 2013 WCIO Program Chairman and the Director of the Division of Diagnostic Imaging and Intervention at Pisa University School of Medicine in Italy and Lead European Principal Investigator for Celsion's Phase III HEAT Study and Ronnie T.P. Poon, MD, MS, PhD, FRCS(Edin), FACS, Professor of Surgery at the University of Hong Kong and Lead...

Experts Discuss Ways To Embed Patient Voices And Values In Clinical Research

2013-04-30 23:22:56

Reforms needed to rebuild public trust in clinical trials There is worldwide concern in the biomedical research community that enrollment in clinical trials is lagging, putting clinical research and consequent benefits to society in jeopardy. Experts explore ways to embed patient voices and values in clinical research in the current issue of Mayo Clinic Proceedings. Clinical trials of new drugs, devices, or procedures require the active participation of human volunteers. Mark A....

NextBio Announces Translational Medicine Partnership with Sanofi

2013-04-30 08:34:37

SANTA CLARA, Calif., April 30, 2013 /PRNewswire/ -- NextBio today announced a multi-year collaboration with Sanofi (NYSE:SNY) aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi's drug research and development, as part of Sanofi's Translational Medicine for Patients (TM4P) program. (Logo: http://photos.prnewswire.com/prnh/20130402/SF86976LOGO) NextBio will provide Sanofi with the NextBio Clinical platform for aggregation, standardization and...

Advanced Biologics adds more patient results showcasing OsteoAMP®'s Superior Fusion Rates Compared to rhBMP-2

2013-04-29 08:28:06

LADERA RANCH, Calif., April 29, 2013 /PRNewswire/ -- Advanced Biologics announced today that they will be presenting expanded data at the American Academy of Neurosurgeons (AANS) meeting this week in New Orleans, LA showcasing a clinical study demonstrating superior lumbar fusion rates for OsteoAMP® when compared to rhBMP-2 (Infuse®, Medtronic). In a blinded, multi-center clinical and radiological study, fusion analysis showed superiority for OsteoAMP® in producing fusions when...

The race toward an interferon free world: The current field of Hepatitis C Virus treatment research, including recent financial deals

2013-04-26 16:21:58

Gilead Sciences Leads the Way in Delivering the First All Oral Treatment for HCV NEW YORK, April 26, 2013 /PRNewswire/ -- Citeline®, an Informa business unit, and the world's leading research authority on pharmaceutical clinical trials has just published an exclusive whitepaper examining the current progress towards a remarkable improvement in the medical treatment for HCV. (Logo: http://photos.prnewswire.com/prnh/20120917/NE75453LOGO ) With news of the impending breakthrough in...

FG Global Launches New Section for Business Use on Website

2013-04-26 12:30:34

Online recruiting network quickens communication between businesses & study/test recruits by offering companies their own dashboard controls on its site. CHICAGO, April 26, 2013 /PRNewswire/ -- Connecting focus group participants to upcoming paid research studies is nothing new for FG Global, but now the company has upped the ante by making it even easier for businesses with last minute recruitment needs. A section for business recruiter use began development just early February and...

Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2

2013-04-26 08:24:20

SAN DIEGO, April 26, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that it will provide a corporate update and discuss first quarter 2013 financial results after the NASDAQ Global Select Market closes on Thursday, May 2, 2013. The conference call and webcast will begin at 5:15 p.m. Eastern Time (2:15 p.m. Pacific Time). The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please...

Scioderm Closes $16 Million In Series A Financing

2013-04-26 08:23:58

Proceeds to fund clinical development through registration for use of SD-101 for the treatment of patients with Epidermolysis Bullosa (EB) DURHAM, N.C., April 26, 2012 /PRNewswire-iReach/ -- Scioderm, a company developing novel dermatology therapeutics, today announced the completion of a Series A financing commitment totaling $16 million. Morgenthaler Ventures led the Series A financing, with Technology Partners as the second investor participating in the round. (Photo:...

Cempra, Inc. Reports First Quarter 2013 Financial and Operating Results

2013-04-25 16:30:35

- Company to Host Conference Call and Webcast at 4:30 p.m. EDT, Today, Apr. 25, 2013 - CHAPEL HILL, N.C., April 25, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the first quarter ended March 31, 2013. The company will host a conference call and webcast at 4:30 p.m. EDT, today. "The first...